Specifically, IGF2BP2 can interact with TMEM44-AS1, enhancing the stability of GPX4 mRNA, increasing the expression level of GPX4, thereby inhibiting ferroptosis in ESCC cells. Here, GPX4 is linked to esophageal squamous cell carcinoma.